Simion F A, Fleischer B, Fleischer S
J Biol Chem. 1984 Sep 10;259(17):10814-22.
As part of the enterohepatic circulation, hepatocytes take up bile acids from the intestines via the hepatic portal blood using a sodium-dependent carrier mechanism and resecrete the bile acids into the bile. In order to assess whether intracellular organelles are involved in the transcellular secretion of bile acids, we measured directly the ability of purified subcellular fractions of rat liver to take up taurocholate using a Millipore filtration assay. Two distinct uptake mechanisms can be discerned, one localized in the plasma membranes and the other in the Golgi and smooth microsomal fractions. Plasma membranes prepared by the method of Fleischer and Kervina (Fleischer, S., and Kervina, M. (1974) Methods Enzymol. 31, 6) take up taurocholate in a saturable manner with an apparent Vmax of 2.4 nmol min-1 mg protein-1 and a Km of 190 microM at 37 degrees C. After preincubation of the membranes with K+ ions, a sodium gradient (100 mM outside) stimulates the uptake rate by 90% with the observed Km unchanged. The stimulation is inhibited by phalloidin but not by bromosulfophthalein. Bile canalicular plasma membranes made according to Kramer et al. (Kramer, W., Bickel, U., Buscher, H. P., Gerok, W., and Kurz, G. (1982) Eur. J. Biochem. 129, 13-24) do not take up taurocholate. The transport by Golgi vesicles and smooth microsomes differs from that in the plasma membrane fraction in that it is not stimulated by a sodium gradient, has a Vmax of 12 nmol min-1 mg protein-1 and a Km of 440 microM at 37 degrees C, and is inhibited by bromosulfophthalein but not by phalloidin. Taurocholate uptake into smooth microsomes is abolished by filipin, an antibiotic that complexes with cholesterol to disrupt the membrane. This suggests that taurocholate uptake occurs into a nonendoplasmic reticulum subfraction since endoplasmic reticulum membranes contain negligible amounts of cholesterol. Little uptake was observed using rough microsomes or mitochondria. A model of transhepatic transport compatible with our observations is that taurocholate uptake into the cytoplasm occurs via the plasma membranes on the sinusoidal side of the hepatocyte; taurocholate is then taken up into smooth vesicles and the Golgi complex and is secreted into the bile by exocytosis as the vesicles fuse with the canalicular plasma membranes.
作为肠肝循环的一部分,肝细胞通过钠依赖性载体机制经肝门静脉血从肠道摄取胆汁酸,并将胆汁酸重新分泌到胆汁中。为了评估细胞内细胞器是否参与胆汁酸的跨细胞分泌,我们使用密理博过滤测定法直接测量了大鼠肝脏纯化亚细胞组分摄取牛磺胆酸盐的能力。可以识别出两种不同的摄取机制,一种定位于质膜,另一种定位于高尔基体和光滑微粒体组分。通过弗莱舍尔和克尔维纳的方法(弗莱舍尔,S.,和克尔维纳,M.(1974年)《酶学方法》31卷,6期)制备的质膜以可饱和的方式摄取牛磺胆酸盐,在37℃时表观Vmax为2.4 nmol min-1 mg蛋白-1,Km为190 μM。在用K+离子预孵育质膜后,钠梯度(外部100 mM)使摄取速率提高90%,观察到的Km不变。这种刺激被鬼笔环肽抑制,但不被溴磺酚酞抑制。根据克莱默等人的方法(克莱默,W.,比克尔,U.,布施尔,H. P.,格罗克,W.,和库尔兹,G.(1982年)《欧洲生物化学杂志》129卷,13 - 24页)制备的胆小管质膜不摄取牛磺胆酸盐。高尔基体囊泡和光滑微粒体的转运与质膜组分中的转运不同,在于它不受钠梯度刺激,在37℃时Vmax为12 nmol min-1 mg蛋白-1,Km为440 μM,并且被溴磺酚酞抑制但不被鬼笔环肽抑制。用制霉菌素处理可消除牛磺胆酸盐向光滑微粒体的摄取,制霉菌素是一种与胆固醇结合以破坏膜的抗生素。这表明牛磺胆酸盐摄取发生在非内质网亚组分中,因为内质网膜含有的胆固醇量可忽略不计。使用粗面微粒体或线粒体时观察到的摄取很少。与我们的观察结果相符的经肝转运模型是牛磺胆酸盐通过肝细胞窦状隙侧的质膜摄取进入细胞质;然后牛磺胆酸盐被摄取到光滑囊泡和高尔基体复合体中,并随着囊泡与胆小管质膜融合通过胞吐作用分泌到胆汁中。